海辰药业(300584)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300584 海辰药业

已收盘 10-10 15:00:00

{"stockData":{"symbol":"300584","market":"SZ","secType":"STK","nameCN":"海辰药业","latestPrice":59.1,"timestamp":1760079825000,"preClose":63.81,"halted":0,"volume":10465970,"delay":0,"changeRate":-0.0738,"floatShares":82110700,"shares":120000000,"eps":0.372,"marketStatus":"已收盘","change":-4.71,"latestTime":"10-10 15:00:00","open":62.62,"high":63.44,"low":58.11,"amount":634000000,"amplitude":0.0835,"askPrice":59.11,"askSize":21,"bidPrice":59.1,"bidSize":232,"shortable":0,"etf":0,"ttmEps":0.372,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1760319000000},"marketStatusCode":5,"adr":0,"adjPreClose":63.81,"symbolType":"stock","openAndCloseTimeList":[[1760059800000,1760067000000],[1760072400000,1760079600000]],"highLimit":70.19,"lowLimit":57.43,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":120000000,"isCdr":false,"pbRate":7.36,"roa":"--","peRate":158.870968,"roe":"2.81%","epsLYR":0.3351,"committee":0.75082,"marketValue":7092000000,"turnoverRate":0.1275,"status":1,"floatMarketCap":4853000000},"requestUrl":"/m/hq/s/300584","defaultTab":"news","newsList":[{"id":"2574143873","title":"海辰药业：截至9月30日股东数为22415户","url":"https://stock-news.laohu8.com/highlight/detail?id=2574143873","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574143873?lang=zh_cn&edition=full","pubTime":"2025-10-10 11:37","pubTimestamp":1760067472,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)10月10日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，请问截止9月30日最新的股东人数是多少？望告知一下，谢谢海辰药业回复：尊敬的投资者您好，截至9月30日，公司股东数为22415户，感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101000014445.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"gpt_icon":0},{"id":"2569220468","title":"海辰药业：截至9月20日股东数为22644户","url":"https://stock-news.laohu8.com/highlight/detail?id=2569220468","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569220468?lang=zh_cn&edition=full","pubTime":"2025-09-22 15:57","pubTimestamp":1758527829,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)09月22日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司9月20日的股东人数是多少？谢谢海辰药业回复：尊敬的投资者您好，截至9月20日，公司股东数为22644户，感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200018021.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"gpt_icon":0},{"id":"2568770256","title":"海辰药业最新公告：硫代硫酸钠注射液获得药品注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2568770256","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568770256?lang=zh_cn&edition=full","pubTime":"2025-09-19 17:08","pubTimestamp":1758272909,"startTime":"0","endTime":"0","summary":"海辰药业公告称，公司于近日收到国家药品监督管理局核准签发的《药品注册证书》，药品名称为硫代硫酸钠注射液，剂型为注射剂，规格为50ml:12.5g，注册分类为化学药品3类。该产品主要用于氰化物中毒，也可用于砷、汞、铅、铋、碘等中毒。海辰药业为上市许可持有人，生产企业为江苏悦兴药业有限公司。该产品的获批丰富了公司产品线，提升了竞争能力，未来有望控制成本，对公司未来业绩的提升将产生积极影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091900025537.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"gpt_icon":0},{"id":"2568605236","title":"海辰药业：暂无芯片领域业务布局计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2568605236","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568605236?lang=zh_cn&edition=full","pubTime":"2025-09-19 11:37","pubTimestamp":1758253078,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)09月19日在投资者关系平台上答复投资者关心的问题。投资者提问：公司未来规划中，有没有计划进军芯片或相关领域？海辰药业回复：尊敬的投资者您好，公司暂无芯片领域业务布局计划，感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091900014595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584","159813"],"gpt_icon":0},{"id":"2568465116","title":"海辰药业：公司将派人参加合肥10月的固态电池大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2568465116","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568465116?lang=zh_cn&edition=full","pubTime":"2025-09-17 15:54","pubTimestamp":1758095651,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)09月17日在投资者关系平台上答复投资者关心的问题。投资者提问：公司的电池材料近期有参加哪些展会的计划？合肥10月的固态电池大会已报名名单未看到贵司报名，贵司计划参加吗？海辰药业回复：尊敬的投资者您好，合肥10月的固态电池大会公司将派人参加，感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091700024891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","159796","BK0239"],"gpt_icon":0},{"id":"2567743081","title":"海辰药业：固态电池材料项目尚处中试及小试阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2567743081","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567743081?lang=zh_cn&edition=full","pubTime":"2025-09-16 15:06","pubTimestamp":1758006383,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)09月16日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司的固态电池业务营业额是多少，有没有量产了？什么时候能量产？海辰药业回复：尊敬的投资者您好，公司在固态电池材料领域的相关项目尚处于中试及小试阶段，具体进展可参见公司半年度报告。感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091600019101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","159796","BK0239"],"gpt_icon":0},{"id":"2567174584","title":"海辰药业：截至9月10日公司股东数为21762户","url":"https://stock-news.laohu8.com/highlight/detail?id=2567174584","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567174584?lang=zh_cn&edition=full","pubTime":"2025-09-16 15:04","pubTimestamp":1758006274,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)09月16日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘您好！请问9月10日公司股东户数多少？谢谢！海辰药业回复：尊敬的投资者您好，截至9月10日，公司股东数为21762户。感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091600019077.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"gpt_icon":0},{"id":"2566951792","title":"海辰药业：截至9月10日公司股东数为21762户","url":"https://stock-news.laohu8.com/highlight/detail?id=2566951792","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566951792?lang=zh_cn&edition=full","pubTime":"2025-09-11 15:03","pubTimestamp":1757574197,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)09月11日在投资者关系平台上答复投资者关心的问题。投资者提问：你好董秘，请问9月10日的股东户数是多少个？海辰药业回复：尊敬的投资者您好，截至9月10日公司股东数为21762户，感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091100018769.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"gpt_icon":0},{"id":"2565684532","title":"A股创新药板块持续上扬，泽璟制药涨超15%，三生国健、海辰药业涨超11%，博瑞医药、昭衍新药涨超9%，长春高新、君实生物、药明康德跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2565684532","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565684532?lang=zh_cn&edition=full","pubTime":"2025-09-05 14:36","pubTimestamp":1757054168,"startTime":"0","endTime":"0","summary":"A股创新药板块持续上扬，泽璟制药涨超15%，三生国健、海辰药业涨超11%，博瑞医药、昭衍新药涨超9%，长春高新、君实生物、药明康德跟涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/09/05143652945282.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1979443071.USD","688166","LU2125910500.SGD","LU1997245094.SGD","BK1576","LU0456842615.SGD","BK0188","06978","LU1969619763.USD","BK1583","BK0057","BK0216","LU1934453819.USD","LU2242644610.SGD","BK0046","300584","BK0075","LU0708995583.HKD","LU1808992512.USD","688180","BK0239","159982","BK0028","688266","LU2488822045.USD","LU2045819591.USD","LU1997245177.USD","BK1161","BK1574","LU0320764599.SGD","LU2328871848.SGD","000661","BK1515","LU2495084118.USD","06127","159992","603127","LU0052750758.USD","LU1046422090.SGD","01877","399300","LU1997244956.HKD","688336","BK1141","603259"],"gpt_icon":0},{"id":"2564704822","title":"海辰药业：截至8月20日公司股东数为20339户","url":"https://stock-news.laohu8.com/highlight/detail?id=2564704822","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564704822?lang=zh_cn&edition=full","pubTime":"2025-09-02 11:33","pubTimestamp":1756784018,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)09月02日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，请问截止8月20日最新的股东人数是多少？望告知一下，谢谢海辰药业回复：尊敬的投资者您好！截至8月20日公司股东数为20339户，感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090200015185.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"gpt_icon":0},{"id":"2562749120","title":"海辰药业股价震荡下行 盘中振幅达6.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562749120","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562749120?lang=zh_cn&edition=full","pubTime":"2025-08-27 20:41","pubTimestamp":1756298503,"startTime":"0","endTime":"0","summary":"截至8月27日收盘，海辰药业报57.12元，较前一交易日下跌1.38%。当日股价呈现宽幅震荡走势，最高触及60.28元，最低下探56.30元，全天振幅达6.87%。成交金额7.56亿元，换手率为15.80%。海辰药业主要从事化学药品的研发、生产和销售，产品涵盖抗感染类、消化系统类、心血管类等多个治疗领域。8月27日盘中，海辰药业股价出现快速波动。早盘9点47分出现快速反弹，五分钟内涨幅超过2%；午后13点04分又出现快速回调，五分钟内跌幅超过2%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/27204152753345.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300584","BK0239"],"gpt_icon":0},{"id":"2562978454","title":"海辰药业收盘下跌1.75%，滚动市盈率155.70倍，总市值69.50亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562978454","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562978454?lang=zh_cn&edition=full","pubTime":"2025-08-26 17:38","pubTimestamp":1756201136,"startTime":"0","endTime":"0","summary":"8月26日，海辰药业今日收盘57.92元，下跌1.75%，滚动市盈率PE达到155.70倍，总市值69.50亿元。从行业市盈率排名来看，公司所处的化学制药行业市盈率平均65.88倍，行业中值39.66倍，海辰药业排名第129位。截至2025年半年报，共有6家机构持仓海辰药业，其中QFII5家、券商1家，合计持股数331.37万股，持股市值1.31亿元。南京海辰药业股份有限公司的主营业务是化学制剂、原料药及中间体的研发、生产、销售。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/26173852703665.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300584","BK0239"],"gpt_icon":0},{"id":"2561534512","title":"海辰药业（300584）2025年中报简析：营收净利润同比双双增长，短期债务压力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2561534512","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561534512?lang=zh_cn&edition=full","pubTime":"2025-08-24 06:17","pubTimestamp":1755987472,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期海辰药业发布2025年中报。截至本报告期末，公司营业总收入3.09亿元，同比上升30.46%，归母净利润2915.77万元，同比上升17.87%。按单季度数据看，第二季度营业总收入1.66亿元，同比上升25.73%，第二季度归母净利润1412.08万元，同比上升24.1%。本报告期海辰药业短期债务压力上升，流动比率达0.97。投资活动产生的现金流量净额变动幅度为58.28%,原因:处置固定资产收回的现金增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082400001745.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584"],"gpt_icon":0},{"id":"2561420816","title":"海辰药业(300584.SZ)发布上半年业绩，归母净利润2915.77万元，增长17.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561420816","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561420816?lang=zh_cn&edition=full","pubTime":"2025-08-22 17:27","pubTimestamp":1755854866,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海辰药业(300584.SZ)发布2025年半年度报告，该公司营业收入为3.09亿元，同比增长30.46%。归属于上市公司股东的净利润为2915.77万元，同比增长17.87%。归属于上市公司股东的扣除非经常性损益的净利润为2885.1万元，同比增长13.07%。基本每股收益为0.243元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1333572.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"海辰药业(300584.SZ)发布上半年业绩，归母净利润2915.77万元，增长17.87%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300584"],"gpt_icon":0},{"id":"2561442624","title":"海辰药业：截至8月20日股东数为20339户","url":"https://stock-news.laohu8.com/highlight/detail?id=2561442624","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561442624?lang=zh_cn&edition=full","pubTime":"2025-08-22 11:37","pubTimestamp":1755833861,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)08月22日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2025年8月20日，公司股东人数有多少海辰药业回复：尊敬的投资者您好！截至8月20日，公司股东数为20339户。感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082200017149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"gpt_icon":0},{"id":"2560055109","title":"海辰药业股价下跌3.24% 盘中一度快速反弹超2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560055109","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560055109?lang=zh_cn&edition=full","pubTime":"2025-08-20 21:25","pubTimestamp":1755696348,"startTime":"0","endTime":"0","summary":"截至2025年8月20日15时，海辰药业股价报55.23元，较前一交易日下跌1.85元，跌幅3.24%。盘中曾出现快速反弹，9点36分时股价升至56.3元，5分钟内涨幅超过2%，成交额达1.31亿元。海辰药业主营化学制药业务，产品涵盖抗感染、消化系统、心血管等领域。公司所属板块包括化学制药、江苏板块、痘病毒防治等。8月20日主力资金净流出9826.37万元，占流通市值比例为2.17%。近五日主力资金累计净流出12813.68万元，占流通市值比例为2.83%。风险提示：股市有风险，投资需谨慎。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/20212552575073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300584","BK0239"],"gpt_icon":0},{"id":"2559467247","title":"海辰药业：截至8月8日公司股东数为22587户","url":"https://stock-news.laohu8.com/highlight/detail?id=2559467247","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559467247?lang=zh_cn&edition=full","pubTime":"2025-08-13 15:03","pubTimestamp":1755068627,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)08月13日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止8月10日公司的股东人数是多少？谢谢海辰药业回复：尊敬的投资者您好！截至8月8日，公司股东数为22587户。感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081300018790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"gpt_icon":0},{"id":"2557582518","title":"新冠药物概念盘中拉升，海辰药业涨12.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557582518","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557582518?lang=zh_cn&edition=full","pubTime":"2025-08-07 09:36","pubTimestamp":1754530561,"startTime":"0","endTime":"0","summary":"08月07日，新冠药物概念盘中拉升，截至09点35分，新冠药物概念整体指数上涨0.57%，报809.080点。从个股上来看，该概念的成分股中，海辰药业涨12.90%，广生堂、贵州百灵、翰宇药业涨幅居前。从资金上来看，截止发稿，新冠药物概念主力净流入为-7351.45万，其中博瑞医药受到资金热捧，主力净流入1020.15万；拉长时间线来看，该板块近20日主力资金净流入-88.67亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807093601a6d7984d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807093601a6d7984d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300584","688166","BK0239"],"gpt_icon":0},{"id":"2557353061","title":"熊去氧胆酸概念盘中拉升，海辰药业涨6.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557353061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557353061?lang=zh_cn&edition=full","pubTime":"2025-08-05 09:35","pubTimestamp":1754357733,"startTime":"0","endTime":"0","summary":"08月05日，熊去氧胆酸概念盘中拉升，截至09点35分，熊去氧胆酸概念整体指数上涨0.87%，报1496.790点。从个股上来看，该概念的成分股中，海辰药业涨6.11%，吉贝尔、科伦药业、新华制药涨幅居前。从资金上来看，截止发稿，熊去氧胆酸概念主力净流入为-3997.34万，其中千红制药受到资金热捧，主力净流入932.30万；拉长时间线来看，该板块近20日主力资金净流入-14.11亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805093533a4756f78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805093533a4756f78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688566","300584","BK0239"],"gpt_icon":0},{"id":"2556805838","title":"海辰药业：截至7月31日收盘公司股东户数为23,324户","url":"https://stock-news.laohu8.com/highlight/detail?id=2556805838","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556805838?lang=zh_cn&edition=full","pubTime":"2025-08-04 15:06","pubTimestamp":1754291183,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)08月04日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止7月31日收盘公司的股东人数是多少？海辰药业回复：尊敬的投资者您好，截至7月31日收盘，公司股东户数为23,324户，感谢关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080400014148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1760145879914,"stockEarnings":[{"period":"1week","weight":0.0537},{"period":"1month","weight":-0.172},{"period":"3month","weight":0.6828},{"period":"6month","weight":2.3448},{"period":"1year","weight":1.6157},{"period":"ytd","weight":1.94}],"compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":0.0222},{"period":"3month","weight":0.1102},{"period":"6month","weight":0.2034},{"period":"1year","weight":0.1802},{"period":"ytd","weight":0.1627}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京海辰药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"22415人(较上一季度减少1.01%)","perCapita":"3663股","listingDate":"2017-01-12","address":"江苏省南京市栖霞区经济技术开发区恒发路1号","registeredCapital":"12000万元","survey":"　　南京海辰药业股份有限公司的主营业务是化学制剂、原料药及中间体的研发、生产、销售。公司的主要产品是心脑血管类、抗感染类、利尿类、消化类、免疫调节类、其他类。","listedPrice":11.11},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海辰药业(300584)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海辰药业(300584)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海辰药业,300584,海辰药业股票,海辰药业股票老虎,海辰药业股票老虎国际,海辰药业行情,海辰药业股票行情,海辰药业股价,海辰药业股市,海辰药业股票价格,海辰药业股票交易,海辰药业股票购买,海辰药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海辰药业(300584)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海辰药业(300584)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}